Pembrolizumab for advanced biliary adenocarcinoma: Results from the multicohort, phase II KEYNOTE-158 study.
暂无分享，去创建一个
R. Kelley | A. Nagrial | D. Oh | A. Marabelle | H. Chung | M. Ueno | S. Pruitt | J. Mahoney | L. Xu | Aurélien Marabelle | Hyun Cheol Chung | M. Ueno | Adnan Nagrial | Lei Xu | Scott K. Pruitt